Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus

Fig. 3

Comparison of DCR and CFR between propofol group and barbiturates group. a DCR of propofol is significantly higher than that of barbiturates in controlling RSE (z = 3.63, P < 0.001). b There is no significant difference in CFR between propofol and barbiturates in the treatment of RSE (z = 0.82, P = 0.382). CI, confidence interval; OR, odds ratio; DCR, disease control rate; CFR, case fatality rate

Back to article page